nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—CYP3A4—Thiotepa—urinary bladder cancer	0.217	0.386	CbGbCtD
Griseofulvin—CYP1A2—Fluorouracil—urinary bladder cancer	0.134	0.239	CbGbCtD
Griseofulvin—CYP1A2—Etoposide—urinary bladder cancer	0.112	0.2	CbGbCtD
Griseofulvin—CYP3A4—Etoposide—urinary bladder cancer	0.0587	0.105	CbGbCtD
Griseofulvin—CYP3A4—Doxorubicin—urinary bladder cancer	0.04	0.0713	CbGbCtD
Griseofulvin—Hyperbilirubinaemia—Thiotepa—urinary bladder cancer	0.00771	0.019	CcSEcCtD
Griseofulvin—Proteinuria—Gemcitabine—urinary bladder cancer	0.00671	0.0165	CcSEcCtD
Griseofulvin—Protein urine present—Gemcitabine—urinary bladder cancer	0.00662	0.0163	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Gemcitabine—urinary bladder cancer	0.00649	0.0159	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Gemcitabine—urinary bladder cancer	0.00624	0.0153	CcSEcCtD
Griseofulvin—Erythema—Mitomycin—urinary bladder cancer	0.00609	0.015	CcSEcCtD
Griseofulvin—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00595	0.0146	CcSEcCtD
Griseofulvin—Neuropathy—Gemcitabine—urinary bladder cancer	0.00554	0.0136	CcSEcCtD
Griseofulvin—Leukopenia—Mitomycin—urinary bladder cancer	0.00546	0.0134	CcSEcCtD
Griseofulvin—Asthenia—Valrubicin—urinary bladder cancer	0.00518	0.0127	CcSEcCtD
Griseofulvin—Neuropathy—Cisplatin—urinary bladder cancer	0.00516	0.0127	CcSEcCtD
Griseofulvin—Confusional state—Mitomycin—urinary bladder cancer	0.00502	0.0123	CcSEcCtD
Griseofulvin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00494	0.0121	CcSEcCtD
Griseofulvin—Candida infection—Etoposide—urinary bladder cancer	0.00481	0.0118	CcSEcCtD
Griseofulvin—Dizziness—Valrubicin—urinary bladder cancer	0.00477	0.0117	CcSEcCtD
Griseofulvin—Neuropathy—Etoposide—urinary bladder cancer	0.00473	0.0116	CcSEcCtD
Griseofulvin—Vomiting—Valrubicin—urinary bladder cancer	0.00459	0.0113	CcSEcCtD
Griseofulvin—Rash—Valrubicin—urinary bladder cancer	0.00455	0.0112	CcSEcCtD
Griseofulvin—Dermatitis—Valrubicin—urinary bladder cancer	0.00455	0.0112	CcSEcCtD
Griseofulvin—Headache—Valrubicin—urinary bladder cancer	0.00452	0.0111	CcSEcCtD
Griseofulvin—Oral candidiasis—Epirubicin—urinary bladder cancer	0.00444	0.0109	CcSEcCtD
Griseofulvin—Nausea—Valrubicin—urinary bladder cancer	0.00429	0.0105	CcSEcCtD
Griseofulvin—Fatigue—Mitomycin—urinary bladder cancer	0.00429	0.0105	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00421	0.0103	CcSEcCtD
Griseofulvin—Oral candidiasis—Doxorubicin—urinary bladder cancer	0.00411	0.0101	CcSEcCtD
Griseofulvin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0041	0.0101	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00399	0.00981	CcSEcCtD
Griseofulvin—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00366	0.009	CcSEcCtD
Griseofulvin—Asthenia—Mitomycin—urinary bladder cancer	0.00357	0.00877	CcSEcCtD
Griseofulvin—Proteinuria—Methotrexate—urinary bladder cancer	0.00343	0.00844	CcSEcCtD
Griseofulvin—Diarrhoea—Mitomycin—urinary bladder cancer	0.0034	0.00837	CcSEcCtD
Griseofulvin—Protein urine present—Methotrexate—urinary bladder cancer	0.00339	0.00832	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Methotrexate—urinary bladder cancer	0.00332	0.00815	CcSEcCtD
Griseofulvin—Dizziness—Mitomycin—urinary bladder cancer	0.00329	0.00809	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00323	0.00795	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.00319	0.00784	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00318	0.00782	CcSEcCtD
Griseofulvin—Vomiting—Mitomycin—urinary bladder cancer	0.00316	0.00777	CcSEcCtD
Griseofulvin—Rash—Mitomycin—urinary bladder cancer	0.00314	0.00771	CcSEcCtD
Griseofulvin—Dermatitis—Mitomycin—urinary bladder cancer	0.00313	0.0077	CcSEcCtD
Griseofulvin—Headache—Mitomycin—urinary bladder cancer	0.00312	0.00766	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Epirubicin—urinary bladder cancer	0.0031	0.00763	CcSEcCtD
Griseofulvin—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00308	0.00757	CcSEcCtD
Griseofulvin—Erythema—Thiotepa—urinary bladder cancer	0.00306	0.00753	CcSEcCtD
Griseofulvin—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00303	0.00744	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00301	0.00741	CcSEcCtD
Griseofulvin—Nausea—Mitomycin—urinary bladder cancer	0.00295	0.00726	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—urinary bladder cancer	0.00287	0.00706	CcSEcCtD
Griseofulvin—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.0028	0.00688	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00276	0.00679	CcSEcCtD
Griseofulvin—Leukopenia—Thiotepa—urinary bladder cancer	0.00274	0.00674	CcSEcCtD
Griseofulvin—Candida infection—Epirubicin—urinary bladder cancer	0.0027	0.00663	CcSEcCtD
Griseofulvin—Neuropathy—Epirubicin—urinary bladder cancer	0.00265	0.00652	CcSEcCtD
Griseofulvin—Agranulocytosis—Etoposide—urinary bladder cancer	0.00263	0.00646	CcSEcCtD
Griseofulvin—Erythema—Gemcitabine—urinary bladder cancer	0.00258	0.00634	CcSEcCtD
Griseofulvin—Erythema—Fluorouracil—urinary bladder cancer	0.00253	0.00623	CcSEcCtD
Griseofulvin—Confusional state—Thiotepa—urinary bladder cancer	0.00252	0.0062	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—urinary bladder cancer	0.00249	0.00613	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—urinary bladder cancer	0.00245	0.00603	CcSEcCtD
Griseofulvin—Erythema—Cisplatin—urinary bladder cancer	0.0024	0.00591	CcSEcCtD
Griseofulvin—Erythema multiforme—Etoposide—urinary bladder cancer	0.00239	0.00588	CcSEcCtD
Griseofulvin—Leukopenia—Gemcitabine—urinary bladder cancer	0.00231	0.00567	CcSEcCtD
Griseofulvin—Leukopenia—Fluorouracil—urinary bladder cancer	0.00227	0.00558	CcSEcCtD
Griseofulvin—Paraesthesia—Thiotepa—urinary bladder cancer	0.00225	0.00552	CcSEcCtD
Griseofulvin—Dyspepsia—Thiotepa—urinary bladder cancer	0.0022	0.00541	CcSEcCtD
Griseofulvin—Fatigue—Thiotepa—urinary bladder cancer	0.00216	0.0053	CcSEcCtD
Griseofulvin—Leukopenia—Cisplatin—urinary bladder cancer	0.00215	0.00529	CcSEcCtD
Griseofulvin—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00212	0.0669	CbGpPWpGaD
Griseofulvin—Confusional state—Fluorouracil—urinary bladder cancer	0.00209	0.00513	CcSEcCtD
Griseofulvin—CYP1A2—Arylamine metabolism—NAT2—urinary bladder cancer	0.00208	0.0653	CbGpPWpGaD
Griseofulvin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00206	0.00507	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00205	0.00504	CcSEcCtD
Griseofulvin—Urticaria—Thiotepa—urinary bladder cancer	0.00199	0.00489	CcSEcCtD
Griseofulvin—Leukopenia—Etoposide—urinary bladder cancer	0.00197	0.00484	CcSEcCtD
Griseofulvin—Insomnia—Gemcitabine—urinary bladder cancer	0.0019	0.00468	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.0019	0.00466	CcSEcCtD
Griseofulvin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00189	0.00464	CcSEcCtD
Griseofulvin—Insomnia—Fluorouracil—urinary bladder cancer	0.00187	0.0046	CcSEcCtD
Griseofulvin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00186	0.00457	CcSEcCtD
Griseofulvin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00184	0.00453	CcSEcCtD
Griseofulvin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00182	0.00448	CcSEcCtD
Griseofulvin—Fatigue—Gemcitabine—urinary bladder cancer	0.00181	0.00446	CcSEcCtD
Griseofulvin—Confusional state—Etoposide—urinary bladder cancer	0.00181	0.00445	CcSEcCtD
Griseofulvin—Asthenia—Thiotepa—urinary bladder cancer	0.00179	0.00441	CcSEcCtD
Griseofulvin—Paraesthesia—Cisplatin—urinary bladder cancer	0.00176	0.00433	CcSEcCtD
Griseofulvin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00173	0.00426	CcSEcCtD
Griseofulvin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00171	0.00421	CcSEcCtD
Griseofulvin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.0017	0.00419	CcSEcCtD
Griseofulvin—Dizziness—Thiotepa—urinary bladder cancer	0.00165	0.00407	CcSEcCtD
Griseofulvin—Urticaria—Fluorouracil—urinary bladder cancer	0.00164	0.00404	CcSEcCtD
Griseofulvin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00162	0.00397	CcSEcCtD
Griseofulvin—Paraesthesia—Etoposide—urinary bladder cancer	0.00161	0.00397	CcSEcCtD
Griseofulvin—Vomiting—Thiotepa—urinary bladder cancer	0.00159	0.00391	CcSEcCtD
Griseofulvin—Rash—Thiotepa—urinary bladder cancer	0.00158	0.00388	CcSEcCtD
Griseofulvin—Dermatitis—Thiotepa—urinary bladder cancer	0.00158	0.00387	CcSEcCtD
Griseofulvin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00157	0.00387	CcSEcCtD
Griseofulvin—Headache—Thiotepa—urinary bladder cancer	0.00157	0.00385	CcSEcCtD
Griseofulvin—Fatigue—Etoposide—urinary bladder cancer	0.00155	0.00381	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00155	0.00381	CcSEcCtD
Griseofulvin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00152	0.00375	CcSEcCtD
Griseofulvin—Hepatitis—Methotrexate—urinary bladder cancer	0.00151	0.00372	CcSEcCtD
Griseofulvin—Asthenia—Gemcitabine—urinary bladder cancer	0.00151	0.00371	CcSEcCtD
Griseofulvin—Nausea—Thiotepa—urinary bladder cancer	0.00149	0.00365	CcSEcCtD
Griseofulvin—Feeling abnormal—Etoposide—urinary bladder cancer	0.00148	0.00364	CcSEcCtD
Griseofulvin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00147	0.00362	CcSEcCtD
Griseofulvin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00144	0.00355	CcSEcCtD
Griseofulvin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00144	0.00354	CcSEcCtD
Griseofulvin—CYP1A2—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00144	0.0453	CbGpPWpGaD
Griseofulvin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00143	0.00352	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00143	0.00352	CcSEcCtD
Griseofulvin—Urticaria—Etoposide—urinary bladder cancer	0.00143	0.00351	CcSEcCtD
Griseofulvin—Hepatitis—Epirubicin—urinary bladder cancer	0.00142	0.00349	CcSEcCtD
Griseofulvin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00142	0.00348	CcSEcCtD
Griseofulvin—Asthenia—Cisplatin—urinary bladder cancer	0.00141	0.00346	CcSEcCtD
Griseofulvin—Dizziness—Fluorouracil—urinary bladder cancer	0.00137	0.00336	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00136	0.00335	CcSEcCtD
Griseofulvin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00134	0.0033	CcSEcCtD
Griseofulvin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00134	0.0033	CcSEcCtD
Griseofulvin—Vomiting—Gemcitabine—urinary bladder cancer	0.00134	0.00329	CcSEcCtD
Griseofulvin—Rash—Gemcitabine—urinary bladder cancer	0.00133	0.00326	CcSEcCtD
Griseofulvin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00133	0.00326	CcSEcCtD
Griseofulvin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00132	0.00325	CcSEcCtD
Griseofulvin—Erythema—Methotrexate—urinary bladder cancer	0.00132	0.00324	CcSEcCtD
Griseofulvin—Headache—Gemcitabine—urinary bladder cancer	0.00132	0.00324	CcSEcCtD
Griseofulvin—Vomiting—Fluorouracil—urinary bladder cancer	0.00132	0.00323	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—urinary bladder cancer	0.00131	0.00322	CcSEcCtD
Griseofulvin—Rash—Fluorouracil—urinary bladder cancer	0.0013	0.00321	CcSEcCtD
Griseofulvin—Dermatitis—Fluorouracil—urinary bladder cancer	0.0013	0.0032	CcSEcCtD
Griseofulvin—Headache—Fluorouracil—urinary bladder cancer	0.0013	0.00319	CcSEcCtD
Griseofulvin—Asthenia—Etoposide—urinary bladder cancer	0.00129	0.00317	CcSEcCtD
Griseofulvin—CYP1A2—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00127	0.04	CbGpPWpGaD
Griseofulvin—Nausea—Gemcitabine—urinary bladder cancer	0.00125	0.00307	CcSEcCtD
Griseofulvin—Vomiting—Cisplatin—urinary bladder cancer	0.00125	0.00307	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00124	0.00305	CcSEcCtD
Griseofulvin—Rash—Cisplatin—urinary bladder cancer	0.00124	0.00304	CcSEcCtD
Griseofulvin—Dermatitis—Cisplatin—urinary bladder cancer	0.00124	0.00304	CcSEcCtD
Griseofulvin—Erythema—Epirubicin—urinary bladder cancer	0.00123	0.00303	CcSEcCtD
Griseofulvin—Diarrhoea—Etoposide—urinary bladder cancer	0.00123	0.00302	CcSEcCtD
Griseofulvin—Nausea—Fluorouracil—urinary bladder cancer	0.00123	0.00302	CcSEcCtD
Griseofulvin—Dizziness—Etoposide—urinary bladder cancer	0.00119	0.00292	CcSEcCtD
Griseofulvin—Leukopenia—Methotrexate—urinary bladder cancer	0.00118	0.0029	CcSEcCtD
Griseofulvin—Nausea—Cisplatin—urinary bladder cancer	0.00116	0.00286	CcSEcCtD
Griseofulvin—Vomiting—Etoposide—urinary bladder cancer	0.00114	0.00281	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—urinary bladder cancer	0.00114	0.00281	CcSEcCtD
Griseofulvin—Rash—Etoposide—urinary bladder cancer	0.00113	0.00279	CcSEcCtD
Griseofulvin—Dermatitis—Etoposide—urinary bladder cancer	0.00113	0.00278	CcSEcCtD
Griseofulvin—Headache—Etoposide—urinary bladder cancer	0.00113	0.00277	CcSEcCtD
Griseofulvin—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00111	0.0349	CbGpPWpGaD
Griseofulvin—Leukopenia—Epirubicin—urinary bladder cancer	0.0011	0.00272	CcSEcCtD
Griseofulvin—Confusional state—Methotrexate—urinary bladder cancer	0.00109	0.00267	CcSEcCtD
Griseofulvin—Nausea—Etoposide—urinary bladder cancer	0.00107	0.00262	CcSEcCtD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00103	0.0325	CbGpPWpGaD
Griseofulvin—Leukopenia—Doxorubicin—urinary bladder cancer	0.00102	0.00251	CcSEcCtD
Griseofulvin—Confusional state—Epirubicin—urinary bladder cancer	0.00102	0.0025	CcSEcCtD
Griseofulvin—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000981	0.0309	CbGpPWpGaD
Griseofulvin—Insomnia—Methotrexate—urinary bladder cancer	0.000973	0.00239	CcSEcCtD
Griseofulvin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000966	0.00238	CcSEcCtD
Griseofulvin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000947	0.00233	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—urinary bladder cancer	0.00094	0.00231	CcSEcCtD
Griseofulvin—Fatigue—Methotrexate—urinary bladder cancer	0.000928	0.00228	CcSEcCtD
Griseofulvin—Insomnia—Epirubicin—urinary bladder cancer	0.000911	0.00224	CcSEcCtD
Griseofulvin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000906	0.0285	CbGpPWpGaD
Griseofulvin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000904	0.00222	CcSEcCtD
Griseofulvin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000887	0.00218	CcSEcCtD
Griseofulvin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000887	0.00218	CcSEcCtD
Griseofulvin—Fatigue—Epirubicin—urinary bladder cancer	0.000868	0.00213	CcSEcCtD
Griseofulvin—Urticaria—Methotrexate—urinary bladder cancer	0.000855	0.0021	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—urinary bladder cancer	0.000843	0.00207	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000837	0.00206	CcSEcCtD
Griseofulvin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00083	0.00204	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00082	0.00202	CcSEcCtD
Griseofulvin—Fatigue—Doxorubicin—urinary bladder cancer	0.000803	0.00198	CcSEcCtD
Griseofulvin—Urticaria—Epirubicin—urinary bladder cancer	0.0008	0.00197	CcSEcCtD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000796	0.0251	CbGpPWpGaD
Griseofulvin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000793	0.00195	CcSEcCtD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000779	0.0245	CbGpPWpGaD
Griseofulvin—Asthenia—Methotrexate—urinary bladder cancer	0.000772	0.0019	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000768	0.00189	CcSEcCtD
Griseofulvin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000742	0.00182	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—urinary bladder cancer	0.00074	0.00182	CcSEcCtD
Griseofulvin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000736	0.00181	CcSEcCtD
Griseofulvin—Asthenia—Epirubicin—urinary bladder cancer	0.000723	0.00178	CcSEcCtD
Griseofulvin—Dizziness—Methotrexate—urinary bladder cancer	0.000712	0.00175	CcSEcCtD
Griseofulvin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000699	0.022	CbGpPWpGaD
Griseofulvin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000689	0.00169	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000687	0.00169	CcSEcCtD
Griseofulvin—Vomiting—Methotrexate—urinary bladder cancer	0.000684	0.00168	CcSEcCtD
Griseofulvin—Rash—Methotrexate—urinary bladder cancer	0.000679	0.00167	CcSEcCtD
Griseofulvin—Dermatitis—Methotrexate—urinary bladder cancer	0.000678	0.00167	CcSEcCtD
Griseofulvin—Headache—Methotrexate—urinary bladder cancer	0.000674	0.00166	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—urinary bladder cancer	0.000669	0.00164	CcSEcCtD
Griseofulvin—Dizziness—Epirubicin—urinary bladder cancer	0.000666	0.00164	CcSEcCtD
Griseofulvin—Vomiting—Epirubicin—urinary bladder cancer	0.00064	0.00157	CcSEcCtD
Griseofulvin—Nausea—Methotrexate—urinary bladder cancer	0.000639	0.00157	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000638	0.00157	CcSEcCtD
Griseofulvin—Rash—Epirubicin—urinary bladder cancer	0.000635	0.00156	CcSEcCtD
Griseofulvin—Dermatitis—Epirubicin—urinary bladder cancer	0.000634	0.00156	CcSEcCtD
Griseofulvin—Headache—Epirubicin—urinary bladder cancer	0.000631	0.00155	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—urinary bladder cancer	0.000616	0.00151	CcSEcCtD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000601	0.0189	CbGpPWpGaD
Griseofulvin—Nausea—Epirubicin—urinary bladder cancer	0.000598	0.00147	CcSEcCtD
Griseofulvin—Vomiting—Doxorubicin—urinary bladder cancer	0.000593	0.00146	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—urinary bladder cancer	0.000588	0.00144	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000587	0.00144	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—urinary bladder cancer	0.000584	0.00144	CcSEcCtD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000572	0.018	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000555	0.0175	CbGpPWpGaD
Griseofulvin—Nausea—Doxorubicin—urinary bladder cancer	0.000554	0.00136	CcSEcCtD
Griseofulvin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000494	0.0156	CbGpPWpGaD
Griseofulvin—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000488	0.0154	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000466	0.0147	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000442	0.0139	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000442	0.0139	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000434	0.0137	CbGpPWpGaD
Griseofulvin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000429	0.0135	CbGpPWpGaD
Griseofulvin—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000426	0.0134	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000404	0.0127	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000401	0.0126	CbGpPWpGaD
Griseofulvin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000381	0.012	CbGpPWpGaD
Griseofulvin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000376	0.0119	CbGpPWpGaD
Griseofulvin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000328	0.0103	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000325	0.0102	CbGpPWpGaD
Griseofulvin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000309	0.00974	CbGpPWpGaD
Griseofulvin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000308	0.0097	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000304	0.00958	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000273	0.00858	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000269	0.00847	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000262	0.00825	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000262	0.00825	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000258	0.00814	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000258	0.00814	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000255	0.00803	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.000242	0.00762	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000236	0.00744	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000233	0.00734	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000213	0.0067	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00021	0.00663	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00021	0.00661	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000208	0.00653	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000199	0.00628	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000199	0.00628	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000197	0.00619	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000194	0.00609	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000188	0.00591	CbGpPWpGaD
Griseofulvin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000183	0.00577	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000182	0.00574	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00018	0.00567	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00018	0.00567	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000164	0.00517	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000162	0.0051	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000158	0.00497	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000142	0.00446	CbGpPWpGaD
Griseofulvin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000142	0.00446	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00014	0.0044	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000138	0.00434	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.00013	0.0041	CbGpPWpGaD
Griseofulvin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.00012	0.00376	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000113	0.00357	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000113	0.00356	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.00011	0.00346	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000109	0.00344	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000108	0.00339	CbGpPWpGaD
Griseofulvin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000106	0.00334	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000105	0.00331	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	9.9e-05	0.00312	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	9.42e-05	0.00297	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	9.42e-05	0.00297	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	9.16e-05	0.00288	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	9.16e-05	0.00288	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	8.74e-05	0.00275	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.47e-05	0.00267	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.21e-05	0.00258	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.17e-05	0.00257	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.03e-05	0.00253	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.03e-05	0.00253	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.65e-05	0.00241	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.65e-05	0.00241	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.61e-05	0.0024	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.58e-05	0.00239	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.51e-05	0.00236	CbGpPWpGaD
Griseofulvin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	6.99e-05	0.0022	CbGpPWpGaD
Griseofulvin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.9e-05	0.00217	CbGpPWpGaD
Griseofulvin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.45e-05	0.00203	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.87e-05	0.00185	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.79e-05	0.00182	CbGpPWpGaD
Griseofulvin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.4e-05	0.0017	CbGpPWpGaD
Griseofulvin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.32e-05	0.00168	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.66e-05	0.00147	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.42e-05	0.00139	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.42e-05	0.00139	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.35e-05	0.00137	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.04e-05	0.00127	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.64e-05	0.00115	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.6e-05	0.00113	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.44e-05	0.00108	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.41e-05	0.00107	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.41e-05	0.00107	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.35e-05	0.00105	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.12e-05	0.000982	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.81e-05	0.000884	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.69e-05	0.000846	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.68e-05	0.000843	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.65e-05	0.000835	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.59e-05	0.000814	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.57e-05	0.00081	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.42e-05	0.000763	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.09e-05	0.000658	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.07e-05	0.000651	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.94e-05	0.00061	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.94e-05	0.00061	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.92e-05	0.000606	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.88e-05	0.000591	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.87e-05	0.000588	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.85e-05	0.000582	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.61e-05	0.000508	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.56e-05	0.000491	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.51e-05	0.000477	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.49e-05	0.00047	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.49e-05	0.00047	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.45e-05	0.000456	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.32e-05	0.000416	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.3e-05	0.00041	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.26e-05	0.000397	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.21e-05	0.000381	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.2e-05	0.000379	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.000377	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.000377	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.000361	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.12e-05	0.000354	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	0.000333	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1e-05	0.000316	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.34e-06	0.000294	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.23e-06	0.000291	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.23e-06	0.000291	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.84e-06	0.000278	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.68e-06	0.000273	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.57e-06	0.00027	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.23e-06	0.000259	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.16e-06	0.000257	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.74e-06	0.000212	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.62e-06	0.000208	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.36e-06	0.0002	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.88e-06	0.000185	CbGpPWpGaD
Griseofulvin—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.61e-06	0.000177	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.2e-06	0.000164	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.54e-06	0.000143	CbGpPWpGaD
Griseofulvin—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.33e-06	0.000136	CbGpPWpGaD
